Abstract
The present study was designed to address the relationship between iron homeostasis and bone metabolism. Cultured hFOB 1.19 osteoblasts were incubated with selected concentrations of hepcidin (50, 100, and 200 nmol/L) for 20 h, harvested for extraction of total RNA and proteins, and the expression of ferroportin 1 was analyzed by RT-PCR and western blotting. The results showed the presence of ferroportin 1 expression in cultured hFOB 1.19 cells. Furthermore, the ferroportin 1 had a similar expression pattern in hFOB cells as in hepatocytes and enterocytes and was downregulated by hepcidin. Our data indicate that osteoblasts are target cells for hepcidin, suggest that hepcidin may have many more targets than previously recognized, and support the role of hepcidin in the development of osteoporosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Weinberg, E.D. 2008. Role of iron in osteoporosis. Pediatric Endocrinology Reviews Suppl 1: 81–85.
Morabito, N., G.T. Russo, A. Gaudio, A. Lasco, A. Catalano, E. Morini, et al. 2007. The “lively” cytokines network in beta-thalassemia major-related osteoporosis. Bone 40: 1588–1594.
Park, C.H., E.V. Valore, A.J. Waring, and T. Ganz. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Journal of Biological Chemistry 276: 7806–7810.
Fleming, R.E., and W.S. Sly. 2002. Mechanisms of iron accumulation in hereditary hemochromatosis. Annual Review of Physiology 64: 663–680.
Maliken, B.D., J.E. Nelson, and K.V. Kowdley. 2011. The hepcidin circuits act: balancing iron and inflammation. Hepatology 53: 1764–1766.
Kwaan, H.C. 2011. Infection and anemia. Infectious Disorders Drug Targets 11: 40–44.
Steinbicker, A.U., C. Sachidanandan, A.J. Vonner, R.Z. Yusuf, D.Y. Deng, C.S. Lai, et al. 2011. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 117: 4915–4923.
Ge, X.H., Q. Wang, Z.M. Qian, L. Zhu, F. Du, W.H. Yung, et al. 2009. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. The Journal of Nutritional Biochemistry 20: 860–865.
Donovan, A., C.A. Lima, J.L. Pinkus, G.S. Pinkus, L.I. Zon, S. Robine, et al. 2005. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metabolism 1: 191–200.
Yamasaki, K., and H. Hagiwara. 2009. Excess iron inhibits osteoblast metabolism. Toxicology Letters 191: 211–215.
Ganz, T. 2006. Hepcidin and its role in regulating systemic iron metabolism. Hematology 507: 29–35.
Zhang, P., Y.J. Xu, D.Y. Zhao, B. Wang, Y. Ma, Z.M. Qian, et al. 2008. Influence of hepcidin and iron ion out of osteoblast on calcium transportation. Chinese Journal of Osteoporosis 14: 504–507.
Zhao, D.Y., Y.J. Xu, P. Zhang, Y.M. Hao, Y. Ma, and B. Wang. 2008. A study on the influence of hepcidin out of osteoblasts on iron transportation. Chinese Journal of Osteoporosis 14: 611–614.
ACKNOWLEDGMENT
This study is partially supported by three Jiangsu provincial grants, BK2008165, RC2007100, and the priority academic program development of Jiangsu higher education institutions.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Xu, Y., Zhang, W., Zhang, P. et al. Downregulation of Ferroportin 1 Expression in hFOB1.19 Osteoblasts by Hepcidin. Inflammation 35, 1058–1061 (2012). https://doi.org/10.1007/s10753-011-9411-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-011-9411-8